May 28th, 2008—A new book, “Image-Guided Radiation Therapy of Prostate Cancer,” is reportedly the first book of its kind to provide information on recommended RT doses, fractionation schedules, target volume delineation and IGRT procedures and policies.

To date, the specific causes of prostate cancer remain unknown; however, among men, prostate cancer is the most common and the second leading cause of cancer death in the U.S. Surgery and radiation therapy are the two most common of the treatment options available.

The holy grail of radiation treatment is precision. That goal now seems closer than ever with new image-guided methods such as PET-CT, 4D-CT and IMRT, which have been shown to provide better targeting accuracy, allowing clinicians to safely increase the dosage administered without increasing toxicity to healthy tissue areas, said the company.

However, accurate dose delivery - as well as dose verification - can present technical challenges. New techniques such as in situ dosimetry, daily dose measurements, robot assisted bracytherapy, deformable registration and dose painting with intensity-modulated radiation therapy (IMRT) all show early promise. Their ongoing evolution ensures the dual prospect of lower toxicity levels and stronger more effective radiation doses coexisting within a successful treatment plan that still manages to deliver less side effects than conventional radiotherapy.

Although IGRT is still in its infancy, its use is more advanced in prostate cancer than other malignancies.

Edited by Richard Valicenti, M.D., Adam Dicker, M.D., and David Jaffray, M.D., the book provides disease stage-specific IGRT guidelines and step-by-step description of current techniques, providing information of critical importance to radiation oncologists, radiologists, urologists and other professionals working in the field.

For more information: www.informahealthcare.com


Related Content

News | Image Guided Radiation Therapy (IGRT)

June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...

Time June 07, 2022
arrow
News | Image Guided Radiation Therapy (IGRT)

May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...

Time May 19, 2022
arrow
News | Radiation Oncology

August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...

Time August 27, 2021
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Image Guided Radiation Therapy (IGRT)

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...

Time February 11, 2020
arrow
News | Radiology Imaging

December 12, 2019 — Philips and the Regional Medical Center (RMC) announced a strategic 5-year partnership agreement ...

Time December 12, 2019
arrow
News | Radiation Therapy

October 22, 2019 — The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) ...

Time October 22, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac System at Dana-Farber/Brigham and Women's Cancer Center. The MRIdian provides for the delivery of radiation therapy to targeted tumors while simultaneously providing continuous magnetic resonance imaging (MRI).

Time October 08, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.

Time September 16, 2019
arrow
Subscribe Now